Does TOSITUMOMAB I-131 Cause Neoplasm malignant? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm malignant have been filed in association with TOSITUMOMAB I-131. This represents 13.2% of all adverse event reports for TOSITUMOMAB I-131.
5
Reports of Neoplasm malignant with TOSITUMOMAB I-131
13.2%
of all TOSITUMOMAB I-131 reports
5
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm malignant From TOSITUMOMAB I-131?
Of the 5 reports, 5 (100.0%) resulted in death.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOSITUMOMAB I-131. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TOSITUMOMAB I-131 Cause?
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)